341 filings
Page 5 of 18
6-K
n2463
1 Feb 21
Kamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in Texas, USA
7:00am
6-K
if32o2xc2x6ynzb0y
13 Jan 21
Kamada Enters into Two New Agreements for the Distribution of Three Biosimilar Products in Israel
7:00am
6-K
n9170o1jur2sy
5 Jan 21
Report of Foreign Private Issuer
7:00am
6-K
0gdyw92h
29 Dec 20
Report of Foreign Private Issuer
7:01am
6-K
46kp6
21 Dec 20
Kamada Added to the NASDAQ Biotechnology Index
7:01am
6-K
3vlrit i2c0i4if
15 Dec 20
Report of Foreign Private Issuer
7:05am
6-K
y0ti5arts4n9
10 Dec 20
Report of Foreign Private Issuer
9:30am
6-K
9x65 6362zwdt
12 Nov 20
Kamada Reports Third Quarter and First Nine Months of 2020 Financial Results, Recent Achievements and Corporate Development
6:59am
6-K
f945sz6qbmia15wqlp
4 Nov 20
Current Report of Foreign Issuer
7:00am
6-K
wr2p3mpis
29 Oct 20
Report of Foreign Private Issuer
5:00pm
6-K
dqs silgdc1c
19 Oct 20
Report of Foreign Private Issuer
7:00am
6-K
hy6ic3p 7h8
7 Oct 20
Kamada Provides Update on 2021 GLASSIA® Supply to Takeda
6:32am
6-K
syt r2z5wi
8 Sep 20
Report of Foreign Private Issuer
7:01am
6-K
tpdb2v35gm b693w9
19 Aug 20
Report of Foreign Private Issuer
7:00am
6-K
57pwy73y31
12 Aug 20
Kamada Announces Changes to its Board of Directors
7:30am
6-K
zjjn36tr2dek2
12 Aug 20
Kamada Reports Second Quarter and First Six Months of 2020 Financial Results, Recent Corporate Achievements and Strong Cash Position
7:00am
6-K
nfako3drob
10 Aug 20
Kamada Announces Enrollment of First Patient in its Phase 1/2 Clinical Trial of its Plasma-Derived
8:00am
6-K
f4o 9a30yef2
5 Aug 20
Report of Foreign Private Issuer
7:00am
6-K
ifuxrn87h
17 Jun 20
Current report (foreign)
7:00am
6-K
1evxgt62zm2q49
18 May 20
Kamada Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Progress
7:01am